메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Park Keun-Ho (Department of Internal Medicine Chosun University Hospital Gwangju Korea.) Jeong Myung Ho (Department of Cardiovascular Medicine Chonnam National University Hospital and Medical School Gwang) Kim Hyun Kuk (Department of Internal Medicine Chosun University Hospital Gwangju Korea.) Ki Young-Jae (Department of Internal Medicine Chosun University Hospital Gwangju Korea.) Kim Sung Soo (Department of Internal Medicine Chosun University Hospital Gwangju Korea.) Choi Dong-Hyun (Department of Internal Medicine Chosun University Hospital Gwangju Korea.) Koh Young-Youp (Department of Internal Medicine Chosun University Hospital Gwangju Korea.) Ahn Youngkeun (Department of Cardiovascular Medicine Chonnam National University Hospital and Medical School Gwang) Kim Hyo-Soo (Department of Internal Medicine Seoul National University Hospital Seoul Korea.) Gwon Hyeon-Cheol (Heart Vascular and Stroke Institute Samsung Medical Center Sungkyunkwan University School of Medici) Rha Seung-Woon (Cardiovascular Center Korea University Guro Hospital Seoul Korea.) Hwang Jin-Yong (Department of Internal Medicine Gyeongsang National University Hospital Jinju Korea.) KAMIR-NIH registry investigators (KAMIR-NIH registry investigators)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.36 No.42
발행연도
2021.11
수록면
1 - 16 (16page)
DOI
10.3346/jkms.2021.36.e268

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Although ticagrelor is known to increase the bleeding risk compared to clopidogrel in East Asian patients, its clinical benefits in patients with acute myocardial infarction (AMI) without high bleeding risk (HBR) remains unknown. Methods: A total of 7,348 patients who underwent successful percutaneous coronary intervention (PCI) from the Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH), between November 2011 and December 2015, were divided into two groups according to the Academic Research Consortium for HBR criteria (KAMIR-HBR, 2,469 patients; KAMIR-non HBR, 4,879 patients). We compared in-hospital major adverse cardiovascular events (MACEs, defined as a composite of cardiac death, non-fatal myocardial infarction, or stroke), and the thrombolysis in myocardial infarction (TIMI) major bleeding between ticagrelor and clopidogrel in the KAMIR-HBR and the KAMIR-non HBR groups, respectively. Results: After propensity score matching, ticagrelor had a higher incidence of in-hospital TIMI major bleeding than clopidogrel in all patients (odds ratio [OR], 1.683; 95% confidence interval [CI], 1.010?2.805; P = 0.046) and the KAMIR-HBR group (OR, 3.460; 95% CI, 1.374?8.714; P = 0.008). However, there was no significant difference in in-hospital TIMI major bleeding between ticagrelor and clopidogrel in the KAMIR-non HBR group (OR, 1.436; 95% CI, 0.722?2.855; P = 0.303). No differences were observed in the cumulative incidences of in-hospital and 6-month MACEs between ticagrelor and clopidogrel in both groups. Conclusions: The bleeding risk of ticagrelor was attenuated in Korean patients with AMI without HBR. Appropriate patient selection could reduce in-hospital bleeding complications associated with ticagrelor in Korean patients with AMI who underwent successful PCI.

목차

등록된 정보가 없습니다.

참고문헌 (28)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0